Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000494864 | SCV000579196 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000222182 | SCV000273709 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV001798714 | SCV002041929 | likely benign | Breast and/or ovarian cancer | 2020-01-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003644934 | SCV004380292 | likely benign | Hereditary breast ovarian cancer syndrome | 2023-03-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005237736 | SCV005883065 | likely benign | not specified | 2024-12-06 | criteria provided, single submitter | clinical testing |